These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1563018)

  • 21. Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.
    Hofsli E; Nissen-Meyer J
    Int J Cancer; 1989 Jul; 44(1):149-54. PubMed ID: 2568347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
    Pirity M; Hevér-Szabó A; Venetianer A
    Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy.
    Sauri H; Kim AT; Shau H
    J Surg Res; 1995 May; 58(5):526-35. PubMed ID: 7745966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line.
    Vanhaesebroeck B; Van Bladel S; Lenaerts A; Suffys P; Beyaert R; Lucas R; Van Roy F; Fiers W
    Cancer Res; 1991 May; 51(9):2469-77. PubMed ID: 1849793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma.
    Savas B; Cole SP; Tsuruo T; Pross HF
    J Clin Immunol; 1996 Nov; 16(6):348-57. PubMed ID: 8946280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.
    Fernandez A; Chen PW; Aggarwal BB; Ananthaswamy HN
    Lymphokine Cytokine Res; 1992 Apr; 11(2):79-85. PubMed ID: 1581420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A; Fidler IJ
    Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
    Morimoto H; Safrit JT; Bonavida B
    J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
    Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W
    Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.
    Walther W; Stein U
    J Cancer Res Clin Oncol; 1994; 120(8):471-8. PubMed ID: 8207045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha is a powerful apoptotic inducer in lymphoid leukemic cells expressing the P-170 glycoprotein.
    Malorni W; Rainaldi G; Tritarelli E; Rivabene R; Cianfriglia M; Lehnert M; Donelli G; Peschele C; Testa U
    Int J Cancer; 1996 Jul; 67(2):238-47. PubMed ID: 8760594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor growth in vivo selects for resistance to tumor necrosis factor.
    Lattime EC; Stutman O
    J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
    Liddil JD; Dorr RT; Scuderi P
    Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology.
    Galea-Lauri J; Richardson AJ; Latchman DS; Katz DR
    J Immunol; 1996 Nov; 157(9):4109-18. PubMed ID: 8892646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.